Biological Information
Background Information:
Wee1 is a protein kinase that plays an important role in the regulation of the cell cycle, particularly in the G2 checkpoint. It functions to inhibit the activity of cyclin-dependent kinase 1 (CDK1), a key regulator of the G2/M transition, by phosphorylating it on a specific tyrosine residue. This phosphorylation inactivates CDK1, preventing the cell from entering mitosis until DNA replication and repair processes have been completed. Research has suggested that Wee1 plays a role in several diseases, including cancer and neurodegenerative diseases. In cancer, inhibition of Wee1 has been suggested as a potential therapy to sensitize cancer cells to DNA damage and improve the efficacy of chemotherapy and radiotherapy. Additionally, Wee1 has been implicated in the regulation of neuronal survival and degeneration, making it a potential target for the treatment of neurodegenerative diseases.
Target Class:
Kinase
Family:
Other Protein Kinase
Sub Family:
Protein Ser/Thr
Protein Name:
Wee1
Protein Aliases:
Wee1A kinase
Accession Number:
NM_003390
UniProt Number:
P30291
Gene Name:
WEE1
Gene ID:
7465
Gene Aliases:
WEE1A
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Bioassay Data
Trademark Statement:
For Research Use Only
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology